Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Future directions in tumor immunotherapy: CTLA4 blockade.

× No keyword cloud information.

8 in total

1. Autoimmune mediated regulation of ovarian tumor growth.

Authors: Cengiz Z Altuntas; Ritika Jaini; Pavani Kesaraju; Daniel Jane-wit; Justin M Johnson; Kelly Covey; Christopher A Flask; Martin Dutertre; Jean-Yves Picard; Vincent K Tuohy
Journal: Gynecol Oncol Date: 2011-10-18 Impact factor: 5.482

Review 2. Immunotherapy for prostate cancer: recent advances, lessons learned, and areas for further research.

Authors: James L Gulley; Charles G Drake
Journal: Clin Cancer Res Date: 2011-06-15 Impact factor: 12.531

3. Therapeutic cancer vaccines in prostate cancer: the paradox of improved survival without changes in time to progression.

Authors: Ravi A Madan; James L Gulley; Tito Fojo; William L Dahut
Journal: Oncologist Date: 2010-08-26

Review 4. Promising novel immunotherapies and combinations for prostate cancer.

Authors: Philip M Arlen; Mahsa Mohebtash; Ravi A Madan; James L Gulley
Journal: Future Oncol Date: 2009-03 Impact factor: 3.404

Review 5. Cancer vaccines: current directions and perspectives in prostate cancer.

Authors: Mahsa Mohebtash; James L Gulley; Ravi A Madan; Theresa Ferrara; Philip M Arlen
Journal: Curr Opin Mol Ther Date: 2009-02

Review 6. Cancer vaccines: moving beyond current paradigms.

Authors: Jeffrey Schlom; Philip M Arlen; James L Gulley
Journal: Clin Cancer Res Date: 2007-07-01 Impact factor: 12.531

Review 7. Current perspectives in prostate cancer vaccines.

Authors: Philip M Arlen; James L Gulley
Journal: Anticancer Agents Med Chem Date: 2009-12 Impact factor: 2.505

8. Trial watch: Monoclonal antibodies in cancer therapy.

Authors: Erika Vacchelli; Alexander Eggermont; Jérôme Galon; Catherine Sautès-Fridman; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal: Oncoimmunology Date: 2013-01-01 Impact factor: 8.110

8 in total